Livzon Pharmaceutical Group Inc - Asset Resilience Ratio

Latest as of September 2025: 4.59%

Livzon Pharmaceutical Group Inc (000513) has an Asset Resilience Ratio of 4.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 000513 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.13 Billion

≈ $164.72 Million USD Cash + Short-term Investments

Total Assets

CN¥24.54 Billion

≈ $3.59 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1994–2024)

This chart shows how Livzon Pharmaceutical Group Inc's Asset Resilience Ratio has changed over time. See 000513 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Livzon Pharmaceutical Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Livzon Pharmaceutical Group Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.13 Billion	4.59%
Total Liquid Assets	CN¥1.13 Billion	4.59%

Asset Resilience Insights

Limited Liquidity: Livzon Pharmaceutical Group Inc maintains only 4.59% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Livzon Pharmaceutical Group Inc Industry Peers by Asset Resilience Ratio

Compare Livzon Pharmaceutical Group Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Livzon Pharmaceutical Group Inc (1994–2024)

The table below shows the annual Asset Resilience Ratio data for Livzon Pharmaceutical Group Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.37%	CN¥89.36 Million ≈ $13.08 Million	CN¥24.46 Billion ≈ $3.58 Billion	+0.04pp
2023-12-31	0.33%	CN¥81.79 Million ≈ $11.97 Million	CN¥25.04 Billion ≈ $3.66 Billion	-0.11pp
2022-12-31	0.43%	CN¥108.09 Million ≈ $15.82 Million	CN¥24.86 Billion ≈ $3.64 Billion	-0.38pp
2021-12-31	0.82%	CN¥182.77 Million ≈ $26.75 Million	CN¥22.37 Billion ≈ $3.27 Billion	+0.69pp
2020-12-31	0.13%	CN¥25.98 Million ≈ $3.80 Million	CN¥20.59 Billion ≈ $3.01 Billion	+0.03pp
2019-12-31	0.10%	CN¥17.19 Million ≈ $2.52 Million	CN¥17.98 Billion ≈ $2.63 Billion	+0.00pp
2018-12-31	0.09%	CN¥15.93 Million ≈ $2.33 Million	CN¥17.44 Billion ≈ $2.55 Billion	+0.04pp
2017-12-31	0.05%	CN¥8.73 Million ≈ $1.28 Million	CN¥15.90 Billion ≈ $2.33 Billion	0.00pp
2016-12-31	0.06%	CN¥6.02 Million ≈ $880.78K	CN¥10.53 Billion ≈ $1.54 Billion	-0.02pp
2015-12-31	0.08%	CN¥6.59 Million ≈ $964.21K	CN¥8.08 Billion ≈ $1.18 Billion	-0.01pp
2014-12-31	0.09%	CN¥6.42 Million ≈ $939.97K	CN¥7.30 Billion ≈ $1.07 Billion	-0.08pp
2013-12-31	0.17%	CN¥11.34 Million ≈ $1.66 Million	CN¥6.57 Billion ≈ $960.81 Million	-0.88pp
2012-12-31	1.05%	CN¥59.32 Million ≈ $8.68 Million	CN¥5.63 Billion ≈ $824.40 Million	+0.09pp
2011-12-31	0.96%	CN¥44.34 Million ≈ $6.49 Million	CN¥4.60 Billion ≈ $673.55 Million	-0.62pp
2010-12-31	1.58%	CN¥57.87 Million ≈ $8.47 Million	CN¥3.66 Billion ≈ $535.86 Million	+0.02pp
2009-12-31	1.56%	CN¥48.89 Million ≈ $7.15 Million	CN¥3.12 Billion ≈ $457.19 Million	-2.60pp
2008-12-31	4.17%	CN¥121.78 Million ≈ $17.82 Million	CN¥2.92 Billion ≈ $427.85 Million	-11.05pp
2007-12-31	15.21%	CN¥448.10 Million ≈ $65.57 Million	CN¥2.95 Billion ≈ $431.05 Million	+9.63pp
2006-12-31	5.58%	CN¥137.11 Million ≈ $20.06 Million	CN¥2.46 Billion ≈ $359.74 Million	+2.32pp
2005-12-31	3.26%	CN¥70.50 Million ≈ $10.32 Million	CN¥2.16 Billion ≈ $316.61 Million	-1.97pp
2004-12-31	5.23%	CN¥115.11 Million ≈ $16.84 Million	CN¥2.20 Billion ≈ $322.21 Million	+2.39pp
2003-12-31	2.84%	CN¥60.46 Million ≈ $8.85 Million	CN¥2.13 Billion ≈ $311.58 Million	+1.93pp
2002-12-31	0.91%	CN¥16.88 Million ≈ $2.47 Million	CN¥1.86 Billion ≈ $271.66 Million	-0.04pp
2001-12-31	0.95%	CN¥15.96 Million ≈ $2.33 Million	CN¥1.68 Billion ≈ $245.28 Million	+0.28pp
2000-12-31	0.67%	CN¥10.70 Million ≈ $1.57 Million	CN¥1.59 Billion ≈ $232.42 Million	+0.57pp
1996-12-31	0.10%	CN¥1.30 Million ≈ $190.33K	CN¥1.32 Billion ≈ $192.68 Million	-0.41pp
1995-12-31	0.51%	CN¥5.67 Million ≈ $830.39K	CN¥1.11 Billion ≈ $162.40 Million	-0.77pp
1994-12-31	1.28%	CN¥11.18 Million ≈ $1.64 Million	CN¥870.12 Million ≈ $127.33 Million	--

pp = percentage points

About Livzon Pharmaceutical Group Inc

SHE:000513 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.81 Billion

CN¥19.20 Billion CNY

Market Cap Rank

#5139 Global

#996 in China

Share Price

CN¥32.65

Change (1 day)

-0.55%

52-Week Range

CN¥32.54 - CN¥43.90

All Time High

CN¥1418.81